Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

O2501

Sigma-Aldrich

Ornithine Transcarbamylase from Streptococcus faecalis

lyophilized powder, ≥300 units/mg protein

Synonym(s):

Carbamoylphosphate:L-Ornithine Carbamoyltransferase, OTCase, Ornithine Carbamoyl Transferase

Sign Into View Organizational & Contract Pricing


About This Item

CAS Number:
Enzyme Commission number:
EC Number:
MDL number:
UNSPSC Code:
12352204

form

lyophilized powder

Quality Level

specific activity

≥300 units/mg protein

composition

Protein, ≥65% Lowry

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

Biochem/physiol Actions

Mutations in ornithine transcarbamylase cause Ornithine transcarbamylase deficiency which prevents the clearance of the byproduct ammonia leading to hyperammonemia. [1]

Unit Definition

One unit will form 1.0 μmole of citrulline from ornithine and carbamyl phosphate per min at pH 8.5 at 37 °C.

Physical form

Lyophilized powder contains Tris buffer salts

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

I G Shabalin et al.
Acta crystallographica. Section F, Structural biology and crystallization communications, 68(Pt 9), 1018-1024 (2012-09-06)
Anabolic ornithine transcarbamoylase (aOTC) catalyzes the reaction between carbamoyl phosphate (CP) and L-ornithine (ORN) to form L-citrulline and phosphate in the urea cycle and L-arginine biosynthesis. The crystal structure of unliganded aOTC from Campylobacter jejuni (Cje aOTC) was determined at
Eddy C Hsueh et al.
Journal of hematology & oncology, 5, 17-17 (2012-05-02)
Recombinant human arginase (rhArg) has been developed for arginine deprivation therapy in cancer, and is currently under clinical investigation. During pre-clinical evaluation, rhArg has exhibited significant anti-proliferative activity in cancer cells deficient in the expression of ornithine carbamoyl transferase (OCT).
QnAs with Arthur L. Horwich. Interview by Prashant Nair.
Arthur L Horwich
Proceedings of the National Academy of Sciences of the United States of America, 109(9), 3193-3193 (2012-02-07)
Hari Iyer et al.
Hemodialysis international. International Symposium on Home Hemodialysis, 16(1), 95-100 (2011-11-22)
Urea cycle disorders are an important and treatable cause of hyperammonemia in the newborn and pediatric age group. Presentation in adolescence or adult life is rare and can manifest as frequent vomiting and behavioral changes. An inherited metabolic disorder should
Tatjana Skrbić et al.
PLoS computational biology, 8(6), e1002504-e1002504 (2012-06-22)
Stochastic simulations of coarse-grained protein models are used to investigate the propensity to form knots in early stages of protein folding. The study is carried out comparatively for two homologous carbamoyltransferases, a natively-knotted N-acetylornithine carbamoyltransferase (AOTCase) and an unknotted ornithine

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service